Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
Cash from Investing Activities
Knight Therapeutics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Investing Activities
CA$29.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Investing Activities
-$2.1B
|
CAGR 3-Years
-102%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
9%
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Investing Activities
CA$293.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Investing Activities
-$59.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash from Investing Activities
-$114.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Cash from Investing Activities
-$27.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Knight Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
29.3m
CAD
Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Cash from Investing Activities amounts to 29.3m CAD.
What is Knight Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-34%
The average annual Cash from Investing Activities growth rates for Knight Therapeutics Inc have been -34% over the past three years .